A technical analysis of Alnylam stock, explaining the recent correction, and what investors should expect next.

The Nasdaq-100 Index has announced its annual reconstitution, with six new companies being added and six being removed, ...

The Nasdaq ($NDAQ) reshuffles its Nasdaq-100 index (NDX) annually in December, and the company announced six new additions to ...

Nasdaq announced the results of the annual reconstitution of the Nasdaq-100 Index, which will become effective prior to market open on Monday, ...

Alnylam Pharmaceuticals faces near-term headwinds from TTR franchise momentum concerns. Click here to read why ALNY stock is ...

Strategy, formerly MicroStrategy, retained its place in the Nasdaq 100 during this year’s rebalancing — its first test since joining the benchmark in December ...

Patients in England and Wales with cardiomyopathy caused by the disorder ATTR amyloidosis will soon be able to access treatment with Alnylam's gene-silencing drug Amvuttra. The ruling by reimbursement ...

The Nasdaq 100 rebalance saw six companies dropped and three new additions, with changes taking effect on December 22, but ...

Strategy remains in the Nasdaq 100 after its first index review, adding to its massive Bitcoin holdings even as shares slide ...

Lululemon Athletica (LULU) to exit the Nasdaq 100 as part of the gauge's annual shakeup, with Seagate (STX) and five others ...

Six firms are set to join the Nasdaq 100 Index as part of its annual reconstitution, the benchmark’s overseer said Friday.

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market ...